Latest News and Press Releases

BRIDGEWATER, N.J., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus,...

BRIDGEWATER, N.J., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of liquid biopsy cancer testing solutions, today announced the Accreditation Committee of the College of...

BRIDGEWATER, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Roy Davis...

At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programs A number of...

BRIDGEWATER, N.J., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer testing solutions, today announced the initiation of a new rectal cancer therapy monitoring study...

HILDEN, Germany and GERMANTOWN, Md. and BRIDGEWATER, N.J., Aug. 21, 2017 (GLOBE NEWSWIRE) -- QIAGEN (NASDAQ:QGEN) (Frankfurt Prime Standard:QIA) and Clinical Genomics, a private company developing...

BRIDGEWATER, N.J., June 09, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, presented data demonstrating the utility of...

BRIDGEWATER, N.J., May 31, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, today announced that data demonstrating the...

BRIDGEWATER, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced it has signed agreements...

BRIDGEWATER, N.J., Jan. 18, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company marketing innovative diagnostic tools for colorectal cancer, today announced that data demonstrating the...